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Advances in drug research not only depend on high throughput screening to evaluate
large numbers of lead compounds but also on the development of in vitro models
which can simulate human tissues in terms of drug permeability and functions. Potential
failures, such as poor permeability or interaction with efflux drug transporters, can be
identified in epithelial Caco-2 monolayer models and can impact a drug candidate’s
progression onto the next stages of the drug development process. Whilst monolayer
models demonstrate reasonably good prediction of in vivo permeability for some
compounds, more developed in vitro tools are needed to assess new entities that enable
closer in vivo in vitro correlation. In this study, an in vitro model of the human intestinal
epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to
mimic the structure of the basement membrane. We assessed Caco-2 cell response to
these materials and investigated the physiological properties of these cells cultured on
the fibrous supports, focusing on barrier integrity and drug-permeability properties. The
obtained data illustrate that 2D Caco-2 Transwell R© cultures exhibit artificially high trans-
epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous
scaffolds which show TEER values similar to ex vivo porcine tissue (also measured in this
study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence
the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that
more closely mimic native gut tissue particularly for studying passive epithelial transport.
We propose that this 3D model is a suitable in vitro model for investigating drug
absorption and intestinal metabolism.
Keywords: Caco-2 cell line, in vitro model, permeability, barrier integrity, electrospun scaffolds
INTRODUCTION
Monolayers of cultured epithelial cells are believed to be effective in vitro tools to assess the
permeation of drugs across epithelial barriers and to probe transporter affinity during the drug
development process (Balimane et al., 2000; Balimane and Chong, 2005; Volpe, 2010); as such, they
are commonly used for this purpose. Caco-2 cells, originally isolated from a colon adenocarcinoma,
develop some of the morphological and functional characteristics when cultured in vitro which are
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akin to absorptive enterocytes found in the small intestine
in vivo. These characteristics include cellular polarization, apical
microvilli and cell-cell tight junctions, and the expression of
some of the enzymes and transporters relevant to understanding
drug disposition at epithelial barriers. For these reasons,
they have been extensively used for the assessment of drug
permeability and are a mainstay of both academic and industrial
pharmaceutical research (Shah et al., 2016; Yi et al., 2017). In
particular, monolayers of cultured human epithelial cells, such
as Caco-2, are used in the application of biowaivers (in vivo
bioavailability studies not considered necessary for product
approval), which can reduce the cost and time it takes to develop
new medicines (Artursson and Karlsson, 1991; Hubatsch et al.,
2007; CDER/FDA, 2015).
Although monolayers of Caco-2 cells provide a simple
platform for in vitro drug development, it is believed that
they still fall short of accurately representing the intestinal
epithelium in vivo. In particular, the epithelial barrier of cultured
Caco-2 cells has been demonstrated to exhibit much higher
trans-epithelial electrical resistance (TEER) compared to gut
excised tissue segments (Artursson et al., 1993). Furthermore,
the prediction of drug absorption kinetics by this model has
been reported to be inaccurate (Yi et al., 2017). In fact, it
has been shown that poorly permeating compounds, some
actively transported drugs, and low molecular weight hydrophilic
compounds do not correlate in Caco-2 permeability studies
compared to human absorption observed in vivo (Balimane
et al., 2006). For instance, polyethylene glycols demonstrate
almost a 100-fold lower permeability in Caco-2 monolayers when
compared to human in vivo (Artursson et al., 1993, 2001). In
addition, the expression level of relevant transporter proteins
(glucose transporter 1, OATP4A1, MRP2, MRP1, and OATP2B1)
was significantly higher (3- to 130-fold) in Caco-2 cells compared
to human, and all examined CYPs demonstrated lower gene
expression in Caco-2 cells compared to human; for instance,
difference for CYP3A4 was 871-fold lower expression in Caco-2
cells (Vaessen et al., 2017).
The lack of anatomical and physiological cues that cells
experience in vitro is one of the foremost reasons for the
differences observed between in vitro and in vivo datasets and
furthermore, there is variation in lab-to-lab monolayer Caco-
2 permeability results (Lee et al., 2017). For epithelial cell
models, the inclusion of additional cell types commonly found
in the intestinal mucosa is one approach which enables the
reconstitution of tissue-like functions in vitro. This includes
the use of mucous producing goblet-like cells, such as HT-
29/HT-29 MTX, endothelial, immune and stromal cell types
that collectively contribute to the dynamic role of the epithelial
barrier (Volpe, 2010; Kim et al., 2012; Harrington et al., 2014;
Shubber et al., 2015). Other strategies include the introduction
of physical and chemical stimuli, usually achieved through
biological scaffolds, which include bioactive chemistries or
structural cues to modulate cell behavior (Schwarzbauer, 1999;
Vllasaliu et al., 2014). Within epithelial tissues, the underlying
extracellular matrix (ECM) of the basement membrane has been
shown to be significant in the function and maintenance of the
epithelium (Schwarzbauer, 1999; Tanjore and Kalluri, 2006).
The aim of this study was to develop a simple, yet more in vivo-
like 3D in vitro model of the human intestinal epithelium. We
employed electrospinning to generate porous, fibrous polymeric
culture supports that mimic the structure of the basement
membrane (Hajiali et al., 2011, 2015, 2018) providing a more
realistic environmental condition for cell culture (Morris et al.,
2014a; Bischel et al., 2016). We show an assessment of Caco2
response to these materials and investigated the physiological
properties of these cells cultured on these fibrous supports,
focusing on barrier integrity and drug-permeability properties.
MATERIALS AND METHODS
Fabrication and Surface Treatment of
Nanofibrous Scaffolds
Polyethylene terephthalate (PET) is a widely used material in cell
culture products including Transwell R© inserts. It exhibits high
resistance to organic solvents, is durable, low cost, and relatively
inert and non-toxic (Moreno et al., 2011). All these factors make
it a useful material for long-term cell culture and has found
applications in tissue engineering for in vitro models (Harrington
et al., 2014; Morris et al., 2014a,b; Haneef and Downes, 2015)
and transplantable graft constructs (Hadjizadeh et al., 2011;
Moreno et al., 2011).
Polyethylene terephthalate flakes (food grade; were procured
from recycled plastic bottles and processed in-house) were
dissolved in a 1:1 solution of dichloromethane and trifluoroacetic
acid (overnight with stirring) and the polymer solution
transferred into a syringe fitted with a blunt needle (18 gauge
spinneret) attached to a syringe pump (Harvard Apparatus,
United Kingdom). Electrospinning was conducted at a flow rate
of 0.5 mL/hr at 14 kV voltage (Glassman High Voltage Inc., Series
EL, Glassman Europe Ltd., United Kingdom; Supplementary
Figure S1). The fibers were collected on a grounded static plate or
rotating collector (a tip-collector distance of 15 cm). The scaffolds
were removed with the aid of 70% (v/v) IMS and allowed to air
dry at room temperature (RT).
The nanofibrous scaffolds were surface coated with type I
bovine collagen (Sigma-Aldrich). For type I bovine collagen
coating, 150 µL of collagen solution (stock and working
concentrations 3.1 mg/mL and 31 µg/mL, respectively) was
gently pipetted ensuring adequate coverage of the entire scaffold.
Samples were incubated at RT under aseptic conditions for 1–2 h.
Any remaining collagen solution was aspirated and the scaffolds
washed with PBS before cell seeding. Control scaffolds included
PET nanofibers with no surface treatment.
Scaffold Characterisation
Scanning Electron Microscopy (SEM)
For acellular Transwell R© and nanofibrous scaffolds, samples
were sputter coated (Leica EMSCD005) with a thin gold
layer for 4–5 min prior to microscopy. Biological samples
were fixed in 3% (v/v) glutaraldehyde in 0.1 M phosphate
buffer pH 7.2 overnight at 4◦C, washed with PBS (x3) and
dehydrated through a series of ethanol concentrations (25–100%
v/v ethanol in dH2O) for 10 min in each. Following dehydration,
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hexamethyldisilazane (HMDS) was added to chemically dry the
samples, removed and allowed to air dry overnight at RT before
sputter coating. Scanning electron microscopy (SEM) was carried
out using a JEOL JSM-6100 scanning electron microscope (JEOL,
United Kingdom). Where necessary, images were processed
using ImageJ software (W. Rasband, National Institute of Health,
United States) taking 60 measurements from 3 independently
produced scaffolds. Inter-fiber distances were used as a measure
of pore size when comparing the differences in nanofibrous and
microfibrous PET scaffolds.
Wettability of the Scaffold Surface
Water contact angle (WCA) was measured using a contact angle
optical tensiometer (CAM 200, KSV Instruments). A single,
10 µL drop of 18.2 M de-ionized water (MilliQ water) was
dispensed onto the surface and WCAs were recorded from the
average of left and right contact angles from 10 frames per sample.
Time of Flight Secondary Ion Mass Spectrometry
(ToF-SIMS) Analysis of Surface Treated Scaffolds
Effective surface adsorption of collagen was investigated
by examining the difference in collagen deposition on the
nanofibrous scaffolds by ToF-SIMs (ToF-SIMS IV, ION-TOF
GmbH, Münster, Germany) with and without washing steps
(using 18.2 M de-ionized MilliQ water) and compared to
untreated PET scaffolds. ToF-SIMS was conducted using a TOF-
SIMS IV from ION-TOF GmbH. Data acquisition was courtesy
of Dr. David Scurr (University of Nottingham). Secondary ion
images were generated from sample spectra and normalized to
the total ion count for each sample. All data were analyzed
using SurfaceLab.
Cell Culture and Assessment of Cell
Viability
Caco-2 (used within 20 passages throughout the study) was
obtained from the Clinical Pathology Laboratory, Queens
Medical Centre, Nottingham and are available from ATCC.
They were cultured in DMEM (Gibco) supplemented with
10% (v/v) foetal calf serum (FCS), 2 mM L-Glutamine
solution, 1% (v/v) antibiotic/antimycotic solution (Gibco; final
concentrations of 10000 units mL−1 penicillin G, 100 mg
mL−1 streptomycin sulfate and 25 µgmL−1 amphotericin B)
at 37◦C, 5% CO2 in 95% relative humidity (RH). Cells were
cultured to around 80% confluence before harvesting cells by
passaging with Trypsin/EDTA (Sigma Aldrich). Cell culture
media was replaced every 2 days. For the initial evaluation
of the scaffold compatibility, Collagen type I and untreated
nanofibrous scaffolds were mounted in 24-well Cell CrownTM
inserts (Scaffdex). The mounted inserts were then placed in
12-well culture plates and seeded with 50,000 cells in 200 µL
per insert. An additional 1 mL culture media was added to
the well of the plate which ensured the insert were adequately
surrounded and bathed in culture media. Following 24 h of
culture at 37◦C, 5% CO2, the PrestoBlue viability assay was
carried out according to manufacturer’s instructions. In brief,
a working solution of 10% (v/v) was prepared from the stock
PrestoBlue solution in HBSS and sterile filtered using a 0.2 µm
pore filter. Samples were washed three times with pre-warmed
PBS and the working solution of PrestoBlue solution applied
to the upper chamber of the inserts. Following a 30 min
incubation period at 37◦C, 5% CO2 with shaking at 150 rpm,
100 µL aliquots were taken from each sample and dispensed
in triplicate into a black 96-well plate. The fluorescence of the
samples was determined using a plate reader (Tecan Infinite 200,
Tecan, United Kingdom) at 530/590 nm (excitation/emission
wavelengths). Subsequent viability assays were conducted on
day 3 and day 6 of culture to provide an initial assessment
of the benefit of the surface treatments on cell adhesion and
proliferation. To evaluate barrier formation, Snapwell R© hanging
inserts (6-well; Corning Life Sciences) were employed as unlike
the CellCrownTM inserts, the Snapwell R© hanging inserts provided
discrete apical and basolateral chambers in a 6-well plate
formate appropriate for assessing barrier formation. The existing
polycarbonate membrane on the securing clip of the Snapwell R©
insert were removed with a scalpel and the nanofiber scaffold
affixed securely to the hanging insert by means of the securing clip
(Supplementary Figure S1). Cells were seeded using the same
cell density (178,000 cells/cm2) as had been previously optimized
for Caco-2 Transwell R© cultures (Hubatsch et al., 2007). A cell
suspension containing 200,000 cells in 500 µL were seeded onto
the upper chamber of the Snapwell R© inserts and cultured for 15–
21 days at 37◦C, 5% CO2 in air prior for TEER evaluation and for
permeability tests.
Trans-Epithelial Electrical Resistance
(TEER) Integrity Measurements
Epithelial barrier formation and integrity were determined
by measuring the resistance to an ion current across the
epithelium. TEER measurements were taken using the EVOM2
Voltohmmeter with STX2 chopstick electrodes (World Precision
Instruments, Florida). Cell inserts were washed with PBS before
the addition of pre-warmed HBSS. TEER ( cm2) values were
taken and calculated by using Eq. 1:
TEER ( cm2) = ( cell layer− blank filter)
×filter surface area (cm2) (1)
Immunocytochemistry
Cells were washed in PBS (x3) before being fixed in 3.7% (v/v)
paraformaldehyde for 15 min and then washed in PBS and
permeabilised with 0.5% (v/v) Triton-X for 5 min at 4◦C. Samples
were then blocked (to avoid non-specific antibody binding) in
a 3% (v/v) BSA, 1% glycine (v/v) blocking solution for 30 min
at ambient temperature. Samples were then washed and blocked
further in 10% (v/v) mouse serum for 30 min at ambient
temperature. The cells were then incubated with the primary
antibody, mouse monoclonal primary tagged human anti-Zona
Occludens-1 Alex Fluor 488 (ZO-1; Invitrogen Life Technologies,
United Kingdom) used at the manufacturers recommended
dilution (5 µg/mL) in blocking solution overnight at 4◦C.
Following this, the samples were washed with PBS and incubated
with a nuclear stain, either DAPI/Hoechst 33342 for 5 min prior
to viewing under fluorescence microscopy.
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Histology and Haematoxylin and Eosin
Staining
The cell samples were fixed in 10% (v/v) formalin solution for
20 min. After washing in PBS, the samples were dehydrated
in a series of ethanol solutions followed by xylene for 1 h
(x2) and then finally in paraffin wax for 1 h (x2) in a tissue
processor (Leica TP1020, Milton Keynes, United Kingdom).
Sections were cut into 8µm sections (Leica RM 2165 microtome)
before mounting on glass slides in preparation for staining.
Samples were paraffin-stripped in xylene, rehydrated and
then stained by Harris haematoxylin and 1% (w/v) alcoholic
eosin. Images were obtained using an inverted Nikon Eclipse
TS100 microscope.
Transmission Electron Microscopy (TEM)
Samples were fixed in 3% (v/v) glutaraldehyde (TAAB
laboratories) in 0.1 M cacodylate buffer overnight at 4◦C
before post-fixation in 1% (v/v) aqueous osmium tetroxide
in 0.05 M phosphate buffer pH 7.2 for 30 min. Samples
were washed in water for 5 min before dehydration in 50%
(v/v) ethanol for 2 min × 5 min steps. Cell scaffolds were
removed from their inserts and stored in 70% (v/v) ethanol
before further dehydration in 90 and 100% (v/v) ethanol
and subsequently 100% (v/v) propylene oxide. Samples were
infiltrated with araldite CY212 resin for 30 min (in a 1:3
resin:acetone mix), followed by 1 h (1:1 resin:acetone mix)
and finally 3 h × 1 h in pure araldite resin. Samples were
then embedded in resin for at least 48 h at 60◦C. Ultra-
thin (90 nm) sections were cut using a diamond knife and
were negatively stained with uranyl acetate and lead citrate.
The sections were then viewed using an FEI Tecnai G2
TEM. Image acquisition was courtesy of Denise McClean of
the School of Life Sciences Imaging (SLIM), University of
Nottingham Medical School.
Porcine Intestinal Segment Preparation
In accordance with the NC3R framework on the reduction and
refinement of animals in research; samples were only obtained
from healthy adult pig cadavers being used for the purposes
of other research projects. The work was conducted according
to United Kingdom Home Office guidelines (Animal Scientific
Procedures Act 2010) and following local AWERB approval (ref
000057). Regional sections from the duodenum (first 25 cm from
the stomach), jejunum (150 cm from the stomach) and ileum
(first 50 cm back from the ileocecal valve) were resected from pig
cadavers (Supplementary Figure S2). Using tweezers the serosa
and muscularis propria (muscle layers) were carefully peeled
away leaving the mucosa. Sections were washed in PBS, cut to
fit the Transwell R© inserts (Corning Life Sciences) and transferred
in 6-well plates. All tissue was kept on the ice and used within a
24 h time period, post-collection.
Drug/Marker Permeability Across the
Epithelial Barrier
Transport studies were conducted using standard, widely
accepted protocols as previously described (Volpe, 2008).
Transport markers were prepared in transport buffer (HBSS,
25 mM HEPES, pH 7.4). Dimethyl sulfoxide (DMSO) was used
to aid solubilisation of poorly soluble drugs at a maximum final
concentration of 0.1% (v/v) used in all transport experiments.
TEER was measured before and after each experiment to
ensure barrier integrity during the experiments and as a control
measure of experimental validity. Inserts were transferred to fresh
plates containing transport buffer (apical/basolateral volumes
were 0.4/1.2 mL and 0.5/6 mL for Transwell R© and Snapwell R©
inserts, respectively). Donor solutions were added to the relevant
compartments and the inserts were then incubated at 37◦C with
shaking at 150 rpm and sampled at intervals of 30 min or 1 h for
1–2 h. Apparent permeability coefficients (Papp) were calculated
according to Eq. 2:
Papp = (dQ/dt)(1/AC0) (2)
Where dQ/dt is the flux of the compound being investigated
(µM s-1), A is the exposed surface area of the insert/scaffold
(cm2) and C0 is the concentration in the apical compartment at
t = 0 (µM).
Compound recovery following permeability assessment were
calculated according the following Eq. 3:
Recovery (%) = [CR(final) × VR(final))
× 100/(CD(initial) × VD(initial)] (3)
Where CD and CR are the donor and receiver compartment
concentrations, VD and VR are the donor and receiver
compartment volumes at t = 0 (initial) or the end of the
experiment (final).
Atenolol and propranolol (Sigma Aldrich) were dissolved in a
minimal volume of DMSO before dilution into transport buffer.
Final DMSO concentrations were less than 0.1% (v/v) and donor
drug/compound concentrations used for all experiments were;
atenolol 1 mM, propranolol 0.5 mM, lucifer yellow (Biotium)
50 µM, FITC-dextran 4 (Sigma Aldrich) and rhodamine 123
(Biotium) 10 µM. Samples were quantified by reverse phase-
HPLC with UV detection (atenolol, propranolol, and verapamil)
or using a plate reader (lucifer yellow, FITC-dextran 4000 and
rhodamine 123). All HPLC was performed using a Kinetix
XB-C18 5 µm, 100 Å pore size, 150 mm × 4.56 mm
column (with a guard column) on an Agilent 1100 HPLC
system. Atenolol and propranolol were analyzed at 225 nm
and 290 nm, respectively. Samples were analyzed using gradient
runs with Milli-Q dH2O, 0.5% TFA (eluent A) and acetonitrile,
0.5% TFA (eluent B).
Statistical Analysis
All statistical analysis was carried out using Graphpad Prism 6
software. Where three or more sets were compared, data were
analyzed by One Way ANOVA with specific post-tests. All the
measured values were expressed as mean ± standard deviation
(SD) and the number of independent experiments (n) is noted in
the figure captions.
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RESULTS AND DISCUSSION
Fibrous Scaffold Characterisation and
Optimisation for Epithelial Cell Culture
Physical and Chemical Properties of Nanofibers
Uniform fibers were fabricated by electrospinning PET
(Figure 1) providing a more porous structure as compared
with the commercial Transwell R© insert (Figures 1A,C). The fiber
diameter could be modulated by altering the polymer solution
concentration and flow rate. Microfibres were fabricated at
polymer concentrations of 20 and 30% (w/v) with average fiber
diameters of 1.1 (±0.4) µm and 2.5 (±0.4) µm, respectively
(Supplementary Figure S3). Nanofibers could be produced
at 10% (w/v), using a lower flow rate of 0.5 mL/h, with
average fibers of 0.5 (±0.2) µm in diameter (Figures 1B,D,E).
The 30% (w/v) polymer solutions exhibited thicker fibers
with larger inter-fiber pore sizes measured by analysis of
scanning electron micrographs. Microfibrous scaffolds had
a mean inter-fiber distance of 15.8 (±8.0) µm compared to
1.3 (±0.5) µm for the nanofibrous scaffolds (Figure 1F). The
fibers produced here are consistent with those reported by
others. Hadjizadeh et al. (2011) reported the fabrication of
PET nanofibers with an average fiber diameter of 400 nm at
7.7% polymer concentration (w/v) and 700 nm at 9% (w/v).
In addition, Morris et al. (2014a) were able to produce fibers
of 250 nm diameter at 8% (w/v). The capacity to fabricate
and modulate nanofibers that closely mimic the dimensions of
natural ECM has made electrospinning an attractive approach
for conducting 3D cell culture (Hajiali et al., 2011). The compact
and decreased porosity of the nanofibrous scaffold provides
high cell-scaffold interaction which can be useful for cells with
barrier properties, whilst an increase in fiber diameter can
enhance scaffold porosity and cell infiltration (Morris et al.,
2014a). As the basement membrane is a supportive structure
which physically separates the epithelial cell layer from the
underlying stroma, it was important that the scaffold would
be suitable for this application and therefore the nanofibers
made from the 10% (w/v) polymer solution were selected
for further study.
Collagen treatment of the scaffolds was characterized via its
impact on surface wettability by measuring the WCA of the
treated scaffold at different coating concentrations compared to
untreated scaffolds (Figure 1G). The untreated scaffolds were
hydrophobic in nature (95.3◦± 12.1◦) before surface coating
with collagen, 35.6◦± 26.2◦ and 21.1◦± 20.1◦ at 31 µg/mL (the
final working concentration used) and 3.1 mg/mL (the stock
concentration), respectively. The adsorption of collagen to the
surface of the nanofibrous PET was investigated further by the
surface analysis technique, ToF-SIMS. Furthermore, the extent of
collagen remaining on the scaffolds after a wash step was studied
as a measure of how strongly adsorbed the collagen was to the
surface of the scaffolds. The presence of nitrogen-containing ion
fragments, some of which have been attributed to specific amino
acids based on literature reports (Wagner and Castner, 2001),
were used as indicators of the presence of collagen. The secondary
FIGURE 1 | (A,C) High and low magnification scanning electron micrographs of conventional Transwell R© PET membrane inserts (pore size 0.4 µm) and (B,D)
nanofibrous scaffolds produced by electrospinning 10% w/v PET; A,B scale bars = 10 µm; (C,D) scale bars = 5 µm. (E) Fiber diameter frequency distributions of
scaffolds produced by electrospinning. (F) Frequency plot of interfibre distances for PET nanofibers produced by electrospinning. All fiber diameter data collected
from n = 60 measurements from 3 independently produced scaffolds. (G) Water contact angle of untreated and collagen type I coated PET scaffolds.
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ion images of representative nitrogen-containing ion fragments
generated from spectral data demonstrate that the collagen coats
the surface of the scaffold in a homogenous fashion for all the
treated samples (Figure 2).
Treatment at a high concentration of collagen (3.1 mg/mL)
displays greater coverage of the surface with nitrogen-containing
ion fragments, specifically C4H8N+, which is attributed to the
amino acid proline in the collagen. Rasi Ghaemi et al. (2016)
also analyzed immobilized Collagen I by ToF SIMS, and showed
that C4H8N+ and CH4N+ can be used to confirm the presence
of collagen on the surface. Comparable surface coverage can be
observed for all three representative ion fragments but at lesser
intensities in all treated samples. The sample treated at the final
working concentration (31 µg/mL) that underwent a washing
step (to confirm that the collagen would remain during cell
culture) still showed a homogenous coating with regard to the
ion fragment distribution albeit at a lower intensity. In addition
to the representative secondary ion images in Figure 2, other
unique nitrogen containing peaks were identified and are listed
in Supplementary Table S1.
FIGURE 2 | Normalized secondary ion images of untreated and collagen type I treated PET scaffolds. Ion images for unique nitrogen-containing peaks in untreated
and type I collagen treated nanofibrous scaffolds. Images have been normalized to the total ion counts. Images are 250 µm × 250 µm.
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Examination of Cell Growth on Surface Treated of
Nanofibrous Scaffolds
Caco-2 culture on the untreated PET nanofibrous scaffolds
demonstrated some inconsistent growth across the surface of
the scaffold where confluence of the epithelial cell layer was
not uniform (Figures 3A–E). Following this finding, surface
treatment of the nanofibrous scaffolds was investigated to
improve cell attachment and growth and to ensure complete
confluence in epithelial cell growth. Initial cell attachment to
the scaffolds (24 h after seeding) was the same on all scaffold
types (Figure 3K). However, cells cultured on the collagen type
I treated scaffolds displayed an increased cell viability compared
to non-treated scaffolds in the following days of culture. Collagen
coating was, therefore employed for all subsequent cell culture
experiments (Figures 3F–J).
Cell confluency and sustaining barrier integrity are important
factors in the design of in vitro epithelial models. Even during
epithelial cell shedding in vivo, neighboring epithelial cells
orchestrate redistribution of tight junctions around the shredded
cell to maintain barrier integrity (Guan et al., 2011; Williams et al.,
2014). Thus, ECM proteins (such as collagen, fibronectin, and
laminin) provide an attachment framework for the adhesion and
growth of epithelial cells in vivo. These adhesion molecules have
been extensively used for cell attachment to various substrates
in vitro (Harnett et al., 2007). It has been previously demonstrated
that not only cell adhesion enhanced in the presence of serum
proteins adsorbed on the membranes, but also their metabolic
function improved on hydrophilic membranes (De Bartolo
et al., 2002). Furthermore, Harnett et al. (2007) showed that
collagen coatings can change the surface energy of substrates and
provide hydrophobic or hydrophilic surfaces, depending on the
underlying substrates. Generally, hydrophilic substrates are more
favorable for cell adhesion although surface topography can also
influence cell attachment (Hajiali et al., 2018).
Evaluation of Caco-2 Barrier Formation
Caco-2 cultures (both on Transwell R© and nanofibrous scaffolds)
were investigated to confirm the formation of an epithelial barrier
and to confirm key features of a functional epithelium (Figure 4).
F-actin immunostained cultures showed a confluent epithelial
sheet on both the Transwell R© and nanofiber culture supports
(Figures 4A,B). The histological cross sections displayed
comparable cellular arrangement and morphology of Caco-2
cultures irrelevant of the culture substrate (Figures 4C,D). As
seen with immunostaining, cellular multi-layering was evident
on the nanofibrous scaffolds, characteristic of the Caco-2 cell line
when differentiated to the small intestinal phenotype, which was
observed but to a lesser extent on the Transwell R© inserts. The
multi-layering of epithelial cells which are cultured in vitro has
been reported (Madden et al., 2018).
FIGURE 3 | Examining the growth of Caco-2 cells on the surface of untreated and treated nanofibrous PET scaffolds. (A,B) Samples were fixed by 3% (v/v)
glutaraldehyde and osmium tetroxide revealing ‘patchy’ cell growth on some scaffolds (red arrows). (C–E) Higher magnification SEM images showed (D) regions of
the cell growth area devoid of cells as well as (E) areas covered by confluent epithelial sheets. (F,G) Collagen type I treated samples were fixed in 3% (v/v)
glutaraldehyde and post-fixed with 1% (v/v) Osmium tetroxide illustrating the complete coverage of the scaffolds surface with cells. (H–J) Further SEM analysis
confirmed confluent coverage of the PET nanofibrous scaffold by a sheet of Caco-2 cells. (K) Cell viability determined using the PrestoBlue assay of Caco-2 cultured
on untreated and collagen type I treated (Col T-1) nanofibrous scaffolds. Values expressed as mean ± SD, n = 3.
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FIGURE 4 | Epithelial barrier properties for Caco-2 cultures on nanofibrous scaffolds compared to Transwell R© based cultures. (A,B) Caco-2 cultures on Transwell R©
and nanofiber supports, respectively, stained for cytoskeletal filament F-actin viewed top down and respective XZ cross sectional views; scale bars = 50 µm. (C,D)
H&E stained Caco-2 cultures on Transwell R© and nanofiber supports, respectively; scale bars = 25 µm. (E) Trans-epithelial electrical resistance of Caco-2 cultured on
Transwell R© and nanofiber scaffolds. Values expressed as mean ± 1 SD; n = 9–15 inserts from a minimum of 3 independent experiments; P-values: ∗∗∗P < 0.001.
(F,G) Immunostained tight junction protein ZO-1 with XZ confocal stack cross sections, on Transwell R© and nanofiber supports, respectively; scale bars = 50 µm.
The barrier integrity of the nanofiber matrix was assessed
by measuring the increase in TEER over a 21 day culture
differentiation period (Figure 4E). The Caco-2 cells cultured
on Transwell R© supports demonstrated high final TEER readings
(>500  cm2 from day 15 onward). In these cultures, TEER
dramatically increased as early as 3 days after cell seeding
to around 200  cm2 (Figure 4E) increasing exponentially.
When Caco-2 cells were cultured on nanofibrous scaffolds, TEER
increased early in culture at around day 6 with cultures displaying
a resistance of∼70 cm2. Subsequently, TEER steadily increased
to 200  cm2 over the next 9 days (day 15) and finally reached a
plateau between day 15 to day 21 (220  cm2).
The expression of the key tight junction protein ZO-1
(Figures 4F,G) identified distinct apical staining (specific to
apical tight junctions) in addition to the typical cobblestone-like
appearance of the epithelium on both substrates. Furthermore,
the morphology of the cells was investigated by TEM (Figure 5).
The comparative cross sectional TEM analysis showed that the
cells expressed characteristic features of differentiation, such
as microvilli (MV) and tight junction complexes (TJ), when
cultured on both substrates.
Porcine intestinal segments were evaluated for their TEER
with respect to regional variation throughout the intestinal tract.
Mean TEER values recorded were 98 (±40), 145 (±80), and
113 (±63)  cm2 (±SD) with significant differences observed
between the jejunum and both the duodenum and ileum
(Figure 6A). The use of resected porcine tissue has recently
been developed as a more predictive tool in drug permeability
assessment (Westerhout et al., 2014). Westerhout et al. (2014)
reported TEER values of jejunal segments of 58 ± 7  cm2
(generally ≤100  cm2 is in agreement with other literature
values; Moeser et al., 2007) which is in relatively good agreement
with our findings (97–145  cm2). Day 21 TEER readings from
both Transwell R© and nanofiber culture supports were compared
with the porcine intestinal segments. Caco-2 Transwell R© cultures
exhibit a comparatively high TEER compared to cells cultured on
the nanofibrous scaffolds which show electrical resistance values
closer to the ex vivo porcine tissue sections (Figure 6A). The
in vivo human TEER value for small intestine and colon has
been reported 50–100  cm2 and 300–400 cm2, respectively
(Srinivasan et al., 2015).
Permeability Studies
Lucifer Yellow (LY)
The permeability of lucifer yellow is used as a method to
evaluate the integrity of Caco-2 monolayers and is used
as a low permeability marker of the paracellular route of
absorption (Konsoula and Barile, 2005). The permeability of
this molecule is passive (i.e., not carrier/transporter mediated)
and therefore the transport would be expected to be equal in
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FIGURE 5 | Representative transmission electron micrographs (TEM) of
Caco-2 cultures. (A,C) Low and (B,D) high magnification micrographs of
Caco-2 cultures on Transwell R© (TW) and nanofibrous (NF) scaffolds,
respectively. The location of the scaffolds, microvilli (MV) and apical tight
junctions (TJ – white arrow) have been highlighted.
both directions (apical to basolateral A to B; and basolateral
to apical B to A). Caco-2 monolayers on Transwell R© displayed
a low flux of LY with permeability coefficient values (Papp)
of 0.30 (±0.13)/0.66 (±0.23) × 10−6 cm s−1 (A to B/B
to A) (Figure 6B). The cultures on the nanofiber scaffolds
exhibited Papp values of 7.14 (±0.4.53)/8.51 (±6.61) which
were significantly higher than Transwell R© Caco-2 cultures. The
porcine intestinal segments also displayed significantly higher
permeability of LY than Transwell R©-based Caco-2 equivalents.
LY Papp values for duodenal, jejunal and ileal sections were
4.66 (±1.19)/2.01 (±0.85), 5.71 (±1.50)/4.31 (±2.58), and 5.58
(±3.93)/3.80 (±3.46) × 10−6 cm s−1, respectively. These
permeability values were not significantly different from those
obtained with Caco-2 cultures on the nanofibers.
FITC-Dextran 4000 (FD4)
FITC-dextran 4000 is a high molecular weight florescent
molecule which, similar to lucifer yellow, is used to assess
passive epithelial transport (Konsoula and Barile, 2005). The
Transwell R© based Caco-2 monolayers displayed a very low Papp
for this type of molecule with permeability coefficients of 0.18
(±0.10)/0.51 (±0.25)× 10−6 cm s−1 (A to B/B to A; Figure 6C).
These values equate to a total molecular flux of less than
0.1%. Caco-2 cultures on nanofibrous scaffolds showed some
evidence of directional transport bias with considerably increased
permeability in the absorptive direction (i.e., A to B) over the
secretory direction (i.e., B to A). Papp values for the nanofiber
Caco-2 cultures were 4.51 (±0.67)/0.75 (±0.74) × 10−6 cm
s−1 with the absorptive permeability being significantly higher
than that of the Transwell R© based cultures. Porcine segments
all displayed FD4 Papps between 2.5–4.8 × 10−6 cm s−1 (AB
direction) and 1.85–5.00 × 10−6 cm s−1 (BA direction). Again,
the permeability coefficients achieved with the ex vivo porcine
tissues were comparable to the nanofiber Caco-2 cultures and
significantly higher than Transwell R© based cultures. FD4 recovery
for porcine intestinal segments was similar to LY with recoveries
ranging from 50–70%.
Rhodamine 123 (Rho 123)
Rhodamine is a known substrate of p-glycoprotein (P-gp/MDR1)
and exhibits active eﬄux which can be demonstrated in vitro
with the Caco-2 model (Troutman and Thakker, 2003). The
Transwell R© based Caco-2 cultures exhibited this mode of
transport with Rho-123 Papp values of 0.82 (±0.51)/3.80
(±0.31) × 10−6 cm s−1 (A to B/B to A; Figure 6D). These
values give an eﬄux ratio of 4.6 which is indicative of active
eﬄux (Hubatsch et al., 2007). Despite being able to observe
this eﬄux phenomenon in the Transwell R© cultures, this was
not detectable in the 3D nanofiber based cultures nor in the
porcine tissue segments. Rho-123 Papp in porcine segments
ranged from 5.6–7.6 × 10−6 cm s−1 for A to B transport and
1.8–3.6× 10−6 cm s−1 B to A permeability. Compound recovery
was notably poor for Rho-123 with recoveries between 37 and
54%. Nanofiber based cell cultures showed increased permeability
over the porcine tissue segments and, similar to the porcine
sections, did not demonstrate the directional bias toward the
eﬄux pathway but rather showed relatively equal permeability in
both directions.
Atenolol (ATN)
Atenolol (ATN) is a commonly utilized drug for Caco-2
based assessment of permeability due to the fact it has been
widely used in in vivo studies and there is general agreement
upon the fraction absorbed (%FA) being roughly 50% of the
administered dose. As such it helps serve as one of several
compounds regularly used to provide a rank order of drugs with
known FA values which contributes to permeability predictions
for novel compounds using the Caco-2 model (Volpe et al.,
2007). Atenolol permeates mainly via the paracellular route of
absorption similar to LY and FD4. Typically low permeability’s
are observed in Caco-2 monolayers (Volpe et al., 2007), in this
study baseline Caco-2 Papp values (AB/BA) for ATN were 0.48
(±0.09)/0.67 (±0.21)× 10−6 cm s−1 (Figure 6E). The nanofiber
based cultures showed increased permeability to atenolol [1.48
(±1.32)/1.44 (±1.04)× 10−6 cm s−1] over the Transwell R© Caco-
2 systems, but the differences were not significant. The porcine
intestinal segment permeability ranged from 3.71–5.58 (A/B)
and 3.22–9.44 (B/A) × 10−6 cm s−1 with an average recovery
of 80% (range between 70 and 95%). As with the majority
of the other tested compounds, no significant gastrointestinal
regional variation was observed in ATN permeability, in either
transport direction. The Papp values were however, significantly
higher than Caco-2 Transwell R© culture for jejunal and ileal
segments in the AB direction (5.08 ± 4.12 × 10−6 cm s−1 and
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FIGURE 6 | (A) Electrical resistance of regional porcine segments in comparison to Transwell R© Caco-2 cultures and nanofibrous scaffold Caco-2 culture (on day 21
of culture). (B–F) The bidirectional apparent permeability coefficients (Papp) of (B) lucifer yellow (LY), (C) FITC-dextran 4000 (D) P-gp substrate rhodamine 123, (E)
atenolol (ATN), and (F) propranolol (PRN). The permeability of materials in absorptive and secretory transport directions was investigated in in vitro models and
compared with ex vivo porcine tissue sections; values represent mean ± SD, n = 9–15 (inserts) from a minimum of two independent experiments for
Transwell R©/nanofiber models, n = 2–4 inserts from 2 donor pigs with respect to porcine tissue samples; P-values: (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001).
5.52 ± 2.97 × 10−6 cm s−1) but only for duodenal tissue in the
BA direction (9.44± 8.56× 10−6 cm s−1).
Propranolol (PRN)
Propranolol (PRN), similar to atenolol, is a commonly used
compound to probe the permeability properties of in vitro
models with a well-known FA (>90%). Due to the lipophilic
properties of PRN, passive transcellular permeability is the
dominant mechanism of permeability across the epithelium
(Lennernäs et al., 1997). Propranolol demonstrated high
permeability in the Transwell R© Caco-2 cultures 30.67
(±6.32)/32.03 (±4.41)× 10−6 cm s−1 (AB/BA) with consistency
in flux in both directions. In the nanofiber based culture system,
PRN displayed vastly higher transport flux than in the Transwell R©
cultures demonstrating more than a two-fold increase in PRN
permeability [86.34 (±12.14)/75.14 (±14.23) × 10−6 cm
s−1; Figure 6F]. The porcine tissue segments exhibited very
low permeability coefficients 7.76–9.6 × 10−6 cm s−1 in the
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A to B direction and 1.85–5.50 × 10−6 cm s−1 in the B to A
direction with a lower recovery with an average of 58% (range
between 35 and 75%).
It is notable that the Caco-2 cultures on the 3D nanofiber
scaffolds displayed lower TEER values than the Transwell R©
equivalents which potentially corroborates the observed increase
in molecular flux. Despite these lower TEER values, the typical
cellular morphology with microvilli and apical tight junction
formation, in addition to ZO-1 staining indicates functional tight
junction expression. The mechanism of the decrease in TEER
has not been clarified in detail but previous work from our
group suggests that it would be a direct result of the increased
porosity of nanofibers over the Transwell R© inserts (Morris et al.,
2014a). In addition, the other plausible cause of this is a decreased
expression of tight junction proteins under 3D culture conditions
(Li et al., 2013). Yu et al. (2012) also observed a significantly lower
TEER value in a 3D model than those obtained using 2D culture.
However, a detailed molecular pathway underlying these similar
results across several different studies has not yet been identified.
We propose here that the results of our study demonstrate that
the structural organization of gut epithelium in the nanofiber
model influences the physiology of Caco-2 cells in such a way that
a more in vivo-like barrier function is observed.
To the authors’ knowledge, the data presented herein is
the first extensive investigation into the permeability properties
of Caco-2 and nanofiber based culture systems as alternative
platforms for predicting drug permeability in vitro. In terms
of molecular permeability, our results from the rhodamine-123
permeability experiments (where the eﬄux ratio of Rho 123 in
the Transwell R© was greater than that in nanofibers and tissue
segments) propose that P-gp is highly active in the Transwell R©
model compared to when cells are cultures on the nanofibers and
in porcine tissue segments. A study by Yi et al. (2017) evaluated
the eﬄux ratio of rhodamine-123 in 2D and 3D models, and they
also showed a decreased eﬄux ratio of Rho 123 in the 3D model.
In addition, Li et al. (2013) studied the eﬄux of digoxin, which
is also a substrate of P-gp and demonstrated a reduction in the
eﬄux permeability of digoxin in the 3D model. The multi-drug
resistance (MDR1) gene encodes an eﬄux transporter P-gp, and
it has been demonstrated that the expression levels of MDR1 in
Caco-2 was 2-fold higher than that of human jejunum (Harwood
et al., 2016). Whilst P-gp functionality was not explored, the
mentioned study suggests Caco-2 cells overexpress MDR1 and
thus most likely over exaggerates eﬄux compared to the in vivo
situation. Furthermore, our data suggested that the P-gp was
either not active or its function was masked in the ex vivo porcine
tissue segments. Expression of P-gp in this model system warrants
further investigation but was not the focus of our work here.
Westerhout et al. (2014) reported Papps for atenolol and
propranolol of 1.25/2.92 × 10−6 cm s−1 (in mini pigs/normal
pigs) and 0.42/25.1× 10−6 cm s−1 (Papp/Papptotal), respectively.
The low Papp value for propranolol was attributed to the poor
compound recovery for which the authors corrected for by
factoring in tissue accumulation (Papptissue) (Rozehnal et al.,
2012). Tissue accumulation is likely to be significant for highly
lipophilic compounds such as propranolol (see Papptotal value
for corrected value which is 60-fold higher than the Papp).
However, a similar correction could not be applied to our data
sets due to the experimental design. Despite this, the calculated
Papps for LY and ATN demonstrated a correlation with reported
human jejunal Papp values by Sjöberg et al. (2013) and by
Rozehnal et al. (2012) (4.02 ± 2.20 and 5.56 ± 2.21 × 10−6 cm
s−1 for LY and mannitol, respectively and 4.11 ± 1.32 and
2.82± 0.65× 10−6 for ATN).
In summary, Caco-2 cells cultured upon a nanofibrous
scaffold more closely represents ex vivo mammalian epithelial
tissue with respect to in vitro permeability, in particular as
a model for passive epithelial transport. This model also
demonstrates permeability coefficients values closer to human
ex vivo tissue (Rozehnal et al., 2012; Sjöberg et al., 2013). Despite
the widespread application of 2D Caco-2 cell models in the
field of drug discovery, its true correlation with the in vivo
situation remains in question (Balimane and Chong, 2005).
For example, 2D monolayers of Caco-2 cells have been known
to under predict the absorption of some compounds, namely
those where paracellular transport is thought to be dominant
(Balimane and Chong, 2005).
CONCLUSION
The aim of this study was to develop a simple yet more in vivo-
like in vitro model of the human intestinal epithelium. We
evaluated the physiological properties of Caco-2 cells cultured
on collagen-coated PET 3D nanofibrous scaffolds, in comparison
to 2D Caco-2 cultures on a Transwell R© membrane and assessed
barrier integrity and drug-permeability properties. Our data
demonstrate that the PET 3D nanofibrous scaffold influences
the barrier integrity of Caco-2 monolayer to confer drug-
absorption properties that more closely mimic native gut tissue
particularly for studying of passive epithelial transport. We
propose therefore that this model is a more suitable in vitro
model for investigating passive drug absorption than currently
employed 2D cultures.
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